The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 May 2008 15:30

RNS Number : 7947U
Aberdeen Grwth Opp VCT2 PLC
19 May 2008
 



Aberdeen Growth Opportunities VCT PLC 

Interim Management Statement 

Net Asset Value

Ordinary share net asset value (NAV) of 103.0p at 31 March 2008 (104.9p at 31 December 2007) S Ordinary share net asset value (NAV) of 100.2p at 31 March 2008 (97.2p at 31 December 2007)

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 March 2008. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 December 2007 adjusted for material developments within the portfolios since that date.  

Investments and disposals

For the Ordinary share portfolio, during the quarter ended 31 March 2008, investments totalling £304,000 were made in three unlisted or AIM-quoted companies. During the same period, disposals of six unlisted or AIM quoted investments generated aggregate proceeds of £355,000 against cost of £325,000.

For the S share portfolio, during the quarter ended 31 March 2008, investments totalling £359,000 were made in three unlisted or AIM-quoted companiesDuring the same period, disposals of three AIM-quoted investments generated aggregate proceeds of £35,000 against cost of £24,000.

There were no other material transactions during the period under review. 

Recent developments 

For the Ordinary share portfolio, between 31 March 2008 and the date of this statement, two further investments totalling £308,000 were made in unlisted companies. During that time, disposals generated proceeds of £188,000 against cost of £103,000.

For the S share portfolio, two further investments totalling £274,000 were made in unlisted companies. During that time, disposals generated proceeds of £100,000 against cost of £47,000.

The Board is not aware of any other events or transactions that have taken place between 31 December 2007 and the date of publication of this statement and which would have had a material impact on the financial position of the Company. 

Issued on behalf of the Board

Aberdeen Asset Management PLC, Secretary

19 May 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUUBPAUPRGCB
Date   Source Headline
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.